Literature DB >> 27417190

The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens.

Eun Young Jang1,2, Chae Ha Yang2, David M Hedges1, Soo Phil Kim2, Jun Yeon Lee2, Tyler G Ekins1, Brandon T Garcia1, Hee Young Kim2, Ashley C Nelson1, Nam Jun Kim2, Scott C Steffensen1.   

Abstract

Methamphetamine (METH) markedly increases dopamine (DA) release in the mesolimbic DA system, which plays an important role in mediating the reinforcing effects of METH. METH-induced DA release results in the formation of reactive oxygen species (ROS), leading to oxidative damage. We have recently reported that ROS are implicated in behavior changes and DA release in the nucleus accumbens (NAc) following cocaine administration. The aim of this study was to evaluate the involvement of ROS in METH-induced locomotor activity, self-administration and enhancement of DA release in the NAc. Systemic administration of a non-specific ROS scavenger, N-tert-butyl-α-phenylnitrone (PBN; 0, 50 and 75 mg/kg, IP) or a superoxide-selective scavenger, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL; 0, 50 and 100 mg/kg, IP), attenuated METH-induced locomotor activity without affecting generalized behavior in METH-naïve rats. PBN and TEMPOL significantly attenuated METH self-administration without affecting food intake. Increased oxidative stress was found in neurons, but not astrocytes, microglia or oligodendrocytes, in the NAc of METH self-administering rats. In addition, TEMPOL significantly decreased METH enhancement of DA release in the NAc. Taken together, these results suggest that enhancement of ROS in the NAc contributes to the reinforcing effect of METH.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  PBN; TEMPOL; dopamine (DA); methamphetamine self-administration; nucleus accumbens; reactive oxygen species (ROS)

Mesh:

Substances:

Year:  2016        PMID: 27417190      PMCID: PMC5237425          DOI: 10.1111/adb.12419

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  43 in total

1.  Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.

Authors:  Samira S Valvassori; Gislaine T Rezin; Camila L Ferreira; Morgana Moretti; Cinara L Gonçalves; Mariana R Cardoso; Emílio L Streck; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatr Res       Date:  2010-03-23       Impact factor: 4.791

Review 2.  Drugs of abuse: anatomy, pharmacology and function of reward pathways.

Authors:  G F Koob
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

Review 3.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

4.  NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain.

Authors:  Donghoon Kim; Byunghyun You; Eun-Kyeong Jo; Sang-Kyou Han; Melvin I Simon; Sung Joong Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

5.  Effects of lithium and valproate on oxidative stress and behavioral changes induced by administration of m-AMPH.

Authors:  Dayane D da-Rosa; Samira S Valvassori; Amanda V Steckert; Felipe Ornell; Camila L Ferreira; Jéssica Lopes-Borges; Roger B Varela; Felipe Dal-Pizzol; Monica L Andersen; João Quevedo
Journal:  Psychiatry Res       Date:  2012-03-17       Impact factor: 3.222

6.  l-DOPA administration enhances 6-hydroxydopamine generation.

Authors:  Himant Maharaj; Deepa Sukhdev Maharaj; Mark Scheepers; Ruth Mokokong; Santy Daya
Journal:  Brain Res       Date:  2005-10-28       Impact factor: 3.252

7.  Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging.

Authors:  Maria Manczak; Youngsin Jung; Byung S Park; Dara Partovi; P Hemachandra Reddy
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

8.  Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.

Authors:  Ikuko Miyazaki; Masato Asanuma; Francisco J Diaz-Corrales; Masaya Fukuda; Kiyoyuki Kitaichi; Ko Miyoshi; Norio Ogawa
Journal:  FASEB J       Date:  2006-01-10       Impact factor: 5.191

9.  Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine.

Authors:  A Moszczynska; S Turenne; S J Kish
Journal:  Neurosci Lett       Date:  1998-10-09       Impact factor: 3.046

10.  Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways.

Authors:  Genevieve Beauvais; Kenisha Atwell; Subramaniam Jayanthi; Bruce Ladenheim; Jean Lud Cadet
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

View more
  18 in total

1.  Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.

Authors:  David M Hedges; J Daniel Obray; Jordan T Yorgason; Eun Young Jang; Vajira K Weerasekara; Joachim D Uys; Frederick P Bellinger; Scott C Steffensen
Journal:  Neuropsychopharmacology       Date:  2017-11-29       Impact factor: 7.853

Review 2.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

3.  Acupuncture inhibition of methamphetamine-induced behaviors, dopamine release and hyperthermia in the nucleus accumbens: mediation of group II mGluR.

Authors:  Nam Jun Kim; Yeonhee Ryu; Bong Hyo Lee; Suchan Chang; Yu Fan; Young S Gwak; Chae Ha Yang; Kyle B Bills; Scott C Steffensen; Jin Suk Koo; Eun Young Jang; Hee Young Kim
Journal:  Addict Biol       Date:  2018-01-23       Impact factor: 4.280

Review 4.  Methamphetamine, neurotransmitters and neurodevelopment.

Authors:  B Čechová; R Šlamberová
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

5.  Prenatal Methamphetamine Hydrochloride Exposure Leads to Signal Transduction Alteration and Cell Death in the Prefrontal Cortex and Amygdala of Male and Female Rats' Offspring.

Authors:  Nayereh Zare; Nader Maghsoudi; Seyed Hamidreza Mirbehbahani; Forough Foolad; Shahrzad Khakpour; Zahra Mansouri; Fariba Khodagholi; Batool Ghorbani Yekta
Journal:  J Mol Neurosci       Date:  2022-09-03       Impact factor: 2.866

Review 6.  r

Authors:  Jacqueline S Womersley; Danyelle M Townsend; Peter W Kalivas; Joachim D Uys
Journal:  Eur J Neurosci       Date:  2018-09-24       Impact factor: 3.386

7.  Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.

Authors:  Jordan T Yorgason; David M Hedges; J Daniel Obray; Eun Young Jang; Kyle B Bills; Mark Woodbury; Ben Williams; Mandy J Parsons; Marilou A Andres; Scott C Steffensen
Journal:  Psychopharmacology (Berl)       Date:  2020-01-21       Impact factor: 4.530

8.  Human Immunodeficiency Virus Type 1 and Methamphetamine-Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons.

Authors:  Carmen Teodorof-Diedrich; Stephen A Spector
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

9.  Epigallocatechin Gallate Mitigates the Methamphetamine-Induced Striatal Dopamine Terminal Toxicity by Preventing Oxidative Stress in the Mouse Brain.

Authors:  Allen L Pan; Ermal Hasalliu; Manjola Hasalliu; Jesus A Angulo
Journal:  Neurotox Res       Date:  2020-02-21       Impact factor: 3.911

10.  The peripheral dopamine 2 receptor antagonist domperidone attenuates ethanol enhancement of dopamine levels in the nucleus accumbens.

Authors:  James Daniel Obray; Eun Young Jang; Anneke M Klomp; Christina A Small; Aaron P Richardson; Joshua J LeBaron; Jin Gyeom Lee; Jordan T Yorgason; Chae Ha Yang; Scott C Steffensen
Journal:  Alcohol Clin Exp Res       Date:  2022-02-01       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.